Dr. Godwin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
505 East 70th Street
Weill Cornell Internal Medicine Associates
New York, NY 10021Phone+1 212-746-4749
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2011 - 2014
- The Warren Alpert Medical School of Brown UniversityClass of 2011
Certifications & Licensure
- PA State Medical License 2014 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 24 citationsPutative Biomarkers of Clinical Benefit With Pembrolizumab in Advanced Urothelial Cancer: Results from the KEYNOTE-045 and KEYNOTE-052 Landmark Trials.Joaquim Bellmunt, Ronald de Wit, Yves Fradet, Miguel A Climent, Daniel P Petrylak
Clinical Cancer Research. 2022-05-13 - 154 citationsLong-Term Outcomes in KEYNOTE-052: Phase II Study Investigating First-Line Pembrolizumab in Cisplatin-Ineligible Patients With Locally Advanced or Metastatic Urothelia...Jacqueline Vuky, Arjun Vasant Balar, Daniel Castellano, Peter H. O'Donnell, Petros Grivas
Journal of Clinical Oncology. 2020-06-17 - 31 citationsProspective study to define the clinical utility and benefit of Decipher testing in men following prostatectomy.J.A. Marascio, Daniel E. Spratt, Jingbin Zhang, Edouard J. Trabulsi, Tiffany Le
Prostate Cancer and Prostatic Diseases. 2020-06-01
Press Mentions
- Clinical Challenge: Immunotherapy-Related Diabetes in Cancer PatientsJune 25th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: